Brief: Arix Bioscience Says Portfolio Co Imara Announces Merger Deal With Enliven Therapeutics
14/10/2022 07:18
Oct 14 (Reuters) - Arix Bioscience PLC ARIX.L :
* REG-ARIX BIOSCIENCE PLC PORTFOLIO COMPANY IMARA ANNOUNCES
MERGER
AGREEMENT WITH ENLIVEN THERAPEUTICS
* ARIX BIOSCIENCE PLC - PORTFOLIO COMPANY IMARA ANNOUNCES
MERGER
AGREEMENT WITH ENLIVEN THERAPEUTICS
* ARIX BIOSCIENCE PLC - TRANSACTION TO CONCURRENTLY RAISE
ABOUT
$165 MILLION IN A PRIVATE FINANCING
Source text for Eikon: ID:nEQ13Mznga
Further company coverage: ARIX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arix Bioscience
See all newsBrief: Arix Bioscience Says Sale Of Harpoon Is Expected To Deliver Net Proceeds Of About $18.9 Mln
Brief: Arix Bioscience Total NAV Of £228.5 MLN As At 31 October 2023
Brief: RTW Biotech To Acquire Arix Bioscience's Assets
RTW Biotech to acquire Arix Bioscience's assets
Brief: Arix Bioscience Says Board Exploring Range Of Strategic Options For Co